TWD 18.75
(-3.35%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -16.62 Million TWD | 72.15% |
2022 | -58.5 Million TWD | -27.43% |
2021 | -42.95 Million TWD | -136.18% |
2020 | 85.9 Million TWD | 920.97% |
2019 | 8.41 Million TWD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 16.38 Million TWD | 138215.38% |
2024 Q1 | 13 Thousand TWD | -99.84% |
2023 Q3 | -6.26 Million TWD | -2679.84% |
2023 FY | - TWD | 72.15% |
2023 Q2 | 243 Thousand TWD | 101.82% |
2023 Q1 | -13.34 Million TWD | 1.55% |
2023 Q4 | 8.34 Million TWD | 233.04% |
2022 FY | - TWD | -27.43% |
2022 Q4 | -13.55 Million TWD | 0.0% |
2021 FY | - TWD | -136.18% |
2020 FY | - TWD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Dr. Wu Skincare Co., Ltd. | 535.45 Million TWD | 103.105% |
Mikobeaute International Co., Ltd. | 127.27 Million TWD | 113.065% |
Shiny Brands Group Co., Ltd. | 536.02 Million TWD | 103.102% |
Sea Mild Biotechnology Co., Ltd. | 19.31 Million TWD | 186.075% |
TCI Co., Ltd. | 1.87 Billion TWD | 100.889% |
Grand Hall Enterprise Co., Ltd. | 393.82 Million TWD | 104.222% |
Tittot Company Limited | -18.92 Million TWD | 12.133% |